← FDA DRUG APPROVALS

FDA ANDA · ANDA087239

AMINOPHYLLINE

Sponsor: ELKINS SINN

APPLICATION
ANDA087239
TYPE
ANDA
ORIGINAL APPROVAL
1981-02-11
LATEST ACTION
1992-09-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

AMINOPHYLLINEDiscontinued
AMINOPHYLLINE 25MG/ML · INJECTABLE · INJECTION

Approval history

1992-09-29Manufacturing (CMC) · Supplement 14AP
1991-03-29Labeling · Supplement 13AP
1991-01-31Labeling · Supplement 12AP
1989-02-09Manufacturing (CMC) · Supplement 10AP
1989-02-09Manufacturing (CMC) · Supplement 11AP
1987-06-08Manufacturing (CMC) · Supplement 8AP
1987-03-25Manufacturing (CMC) · Supplement 7AP
1986-11-03Manufacturing (CMC) · Supplement 6AP
1985-11-18Manufacturing (CMC) · Supplement 5AP
1983-02-14Manufacturing (CMC) · Supplement 2AP
1981-02-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →